Detalhe da pesquisa
1.
pRAD50: a novel and clinically applicable pharmacodynamic biomarker of both ATM and ATR inhibition identified using mass spectrometry and immunohistochemistry.
Br J Cancer
; 119(10): 1233-1243, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30385821
2.
Orally Bioavailable and Blood-Brain Barrier-Penetrating ATM Inhibitor (AZ32) Radiosensitizes Intracranial Gliomas in Mice.
Mol Cancer Ther
; 17(8): 1637-1647, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29769307
3.
Phosphatidylcholine-specific phospholipase C activity is necessary for the activation of STAT6.
J Immunol
; 171(8): 4203-9, 2003 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-14530343